Baca berita tanpa iklan. Gabung Kompas.com+
June 29, 2021, 11.04 PM

JAKARTA, KOMPAS.com - Food and Drug Supervisory Agency (BPOM) has approved clinical trials on Ivermectin, a drug used to treat parasitic infection in livestock and humans, for the Covid-19 treatment.

Head of BPOM Penny Lukito said her office has allowed the use of Ivermectin as an anthelmintic after global data shows that it is also used for the Covid-19 treatment. The clinical trials will be conducted by the Ministry of Health in eight hospitals. 

"A similar opinion was conveyed by the US FDA [Food and Drug Administration] and the EMA [European Medicines Agency]. However, we still have to collect clinical trial data, which is not conclusive at this time," said Penny in a virtual press conference on Monday, June 28.

Deputy for BPOM Drug, Narcotics, Psychotropic, Precursor and Addictive Substance Control (ONPPZA) Rita Endang said clinical trials would usually take three months to see the safety and efficacy of Ivermectin on patients.

Minister of State-Owned Enterprises Erick Thohir said his party was ready to produce 4.5 million tablets of Ivermectin after the completion of the clinical trials.

"We will produce 4.5 million tablets [Ivermectin] if it turns out to be good for all of us," Erick said on Monday.

Erick also said the government is monitoring the availability of antiviral drugs such as Oseltamivir, Pafiviravir, and Remdesivir.

Meanwhile, according to Presidential Chief of Staff Moeldoko, the Front Line Covid-19 Critical Care (FLCCC) Alliance claimed 33 countries have used Ivermectin to treat Covid-19, including Brazil, Zimbabwe, Japan, and India.

SOE Minister Erick Thohir announced that the government-owned pharmaceutical company, Indofarma Ltd. had succeeded in making a drug that helped cure Covid-19.INAF SOE Minister Erick Thohir announced that the government-owned pharmaceutical company, Indofarma Ltd. had succeeded in making a drug that helped cure Covid-19.

Head of BPOM Penny Lukito during a virtual press conference on Ivermectin's Clinical Trial Implementation Approval (PPUK), on Monday, June 28.BPOM RI Head of BPOM Penny Lukito during a virtual press conference on Ivermectin's Clinical Trial Implementation Approval (PPUK), on Monday, June 28.

Presidential Chief of Staff Moeldoko claimed, as many as 15 countries suppressed Covid-19 cases because they used the drug Ivermectin.Tribun News Presidential Chief of Staff Moeldoko claimed, as many as 15 countries suppressed Covid-19 cases because they used the drug Ivermectin.

Ivermectin was given to help with the handling of Covid-19 cases in Semarang City, Central Java on Friday, June 11, 2021.KOMPAS.com/RISKA FARASONALIA Ivermectin was given to help with the handling of Covid-19 cases in Semarang City, Central Java on Friday, June 11, 2021.

(Writers: Haryanti Puspa Sari, Fitria Chusna Farisa | Editors: Diamanty Meiliana, Krisiandi)

Sources:

https://nasional.kompas.com/read/2021/06/29/06040291/ivermectin-obat-cacing-yang-dapat-izin-uji-klinik-untuk-obat-covid-19

https://nasional.kompas.com/read/2021/06/28/12254331/moeldoko-klaim-15-negara-berhasil-lawan-covid-19-dengan-ivermectin

Dapatkan update berita pilihan dan breaking news setiap hari dari Kompas.com. Mari bergabung di Grup Telegram "Kompas.com News Update", caranya klik link https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.

Baca berita tanpa iklan. Gabung Kompas.com+


Baca berita tanpa iklan. Gabung Kompas.com+
Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
April 14, 2023, 12.38 PM

Indonesia Detects New Covid Arcturus Variant

News
April 5, 2023, 05.16 PM

ASEAN to Finalize Agreement on EV Ecosystem

Baca berita tanpa iklan. Gabung Kompas.com+
Baca berita tanpa iklan. Gabung Kompas.com+

MOST POPULAR

Baca berita tanpa iklan. Gabung Kompas.com+
Baca berita tanpa iklan. Gabung Kompas.com+
Close Ads
Oke
Baca berita tanpa iklan. Gabung Kompas.com+